Please use this identifier to cite or link to this item:
Title: The effect of tigecycline on the binding of fluoroquinolones to human serum albumin
Authors: Jelic, Ratomir
Stojanović E.
Beric J.
Odovic J.
Journal: Serbian Journal of Experimental and Clinical Research
Issue Date: 1-Mar-2018
Abstract: © 2018, University of Kragujevac, Faculty of Science. All rights reserved. The co-administration of several drugs in multidrug therapy may alter the binding of each drug to human serum albumin (HSA) and, thus, their pharmacology effect. Therefore, in this study, the interaction mechanism between HSA and two fluoroquinolones (FQs), sparfloxacin (SPF) and levofloxacin (LVF), was investigated using fluorescence and absorption methods in the absence and presence of the competing drugtigecycline (TGC). The the UV-Vis and fluorescence spectroscopy results showed that the fluorescence quenching of HSA was a result of the formation of the HSA-SPF and HSA-LVF complexes. The fluorescence quenching of HSA-TGC revealed that tigecycline can regulate the binding sites, binding mode and binding affinity of fluoroquinolones. The binding constants (KA) and binding sites (n) of the interaction systems were calculated. The results confirmed that the KA values of the HSA-FQ system decreased in the presence of TGC, indicating that TGC can affect the binding ability of FQ for HSA. This interaction may increase the free plasma concentration of unbound FQ and enhance their pharmacology effect.
Type: Article
DOI: 10.1515/SJECR-2017-0006
ISSN: 18208665
SCOPUS: 85044772700
Appears in Collections:Faculty of Medical Sciences, Kragujevac
[ Google Scholar ]

Page views(s)




Files in This Item:
File Description SizeFormat 
10.1515-SJECR-2017-0006.pdf2.15 MBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.